← Amerant Bancorp Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) before attribution of noncontrolling interest | — | — | $51.3m | ($1.7m) | $110.3m | $62.0m | $30.8m | ($15.8m) | $52.4m | |
| Net premium amortization on securities | $19.4m | $16.9m | $14.3m | $14.9m | $12.6m | $8.5m | $4.8m | $4.6m | $2.2m | |
| Depreciation and amortization | $9.0m | $8.5m | $7.1m | $9.4m | $7.3m | $5.9m | $6.8m | $6.6m | $6.7m | |
| Deferred taxes and others | $14.7m | $2.3m | ($2.1m) | ($11.5m) | $6.0m | $5.2m | ($5.5m) | $165k | $5.7m | |
| Impairment on investment carried at cost | — | — | — | — | $0 | $0 | $2.0m | $0 | $0 | |
| Gain on early extinguishment of advances from the FHLB, net | $0 | ($882k) | $886k | $73k | $2.5m | ($10.7m) | ($40.1m) | ($1.6m) | ($12k) | |
| Provision for credit losses | ($3.5m) | $375k | ($3.1m) | $88.6m | ($16.5m) | $13.9m | $61.3m | $60.5m | $42.6m | |
| Stock-based compensation expense | $0 | $166k | $6.4m | $2.3m | $4.8m | $5.8m | $6.8m | $5.0m | $5.0m | |
| Losses on loans held for sale carried at the lower of cost or fair value | — | — | — | — | $0 | $159k | $43.1m | $0 | $15.7m | |
| Loss on sale of repossessed assets | — | — | — | — | $0 | $0 | $2.6m | $0 | $0 | |
| Change in cash surrender value of bank owned life insurance | ($5.5m) | ($5.8m) | ($5.7m) | ($5.7m) | ($5.5m) | ($5.4m) | ($5.2m) | ($9.3m) | ($10.1m) | |
| Securities (gains),losses, net | — | $999k | ($2.6m) | ($27.0m) | ($3.7m) | $3.7m | $11.0m | $76.9m | ($5.1m) | |
| Derivative losses (gains), net | — | — | — | $0 | $0 | ($455k) | ($28k) | $196k | $3.4m | |
| Gain on sale of loans, net | — | — | $0 | $0 | ($4.3m) | $320k | ($4.4m) | ($8.1m) | ($5.4m) | |
| Gain on sale of Houston Franchise | — | — | — | — | — | $0 | $0 | ($12.6m) | $0 | |
| Proceeds from sales and repayments of mortgage loans originated for sale (at fair value) | — | — | $0 | $0 | $20.9m | $143.1m | $286.5m | $380.8m | $143.7m | |
| Originations and purchases of mortgage loans originated for sale (at fair value) | — | — | $0 | $0 | ($35.1m) | ($286.7m) | ($343.5m) | ($419.1m) | ($107.5m) | |
| Accrued interest receivable and other assets | ($1.3m) | $3.7m | $15.4m | ($446k) | ($4.4m) | ($15.3m) | ($34.4m) | $3.8m | $8.2m | |
| Account payable, accrued liabilities and other liabilities | $14.4m | ($8.9m) | ($3.3m) | ($13.4m) | $35.0m | $21.1m | $4.1m | ($3.6m) | ($20.5m) | |
| Available for sale | $655.3m | $280.0m | $497.7m | $782.0m | $446.4m | $246.4m | $104.2m | $694.1m | $523.7m | |
| Trading Securities | — | — | — | — | — | — | $0 | $0 | ($118.4m) | |
| Federal Home Loan Bank and Federal Reserve Bank stock | ($41.0m) | ($27.7m) | ($43.2m) | ($9.8m) | ($4.6m) | ($38.0m) | ($83.1m) | $43.0m | $9.5m | |
| Equity securities with readily determinable fair value not held for trading | — | $0 | $0 | ($29k) | $23.5m | $252k | $11.2m | $0 | $0 | |
| Held to maturity | $315k | $4.4m | $10.7m | $15.1m | $39.7m | $15.4m | $14.7m | $9.6m | $0 | |
| Trading | — | — | — | — | — | — | $0 | $0 | $121.2m | |
| Proceeds from surrender of bank owned life insurance | — | — | — | — | — | $0 | $0 | $62.7m | $0 | |
| Net decrease (increase) in loans | ($393.6m) | ($33.2m) | ($98.3m) | ($199.9m) | $93.3m | ($1.3b) | ($509.7m) | ($1.1b) | $343.4m | |
| Proceeds from loan portfolio sales | $85.8m | $173.5m | $267.8m | $71.6m | $166.3m | $84.0m | $109.2m | $543.1m | $137.9m | |
| Purchase of bank owned life insurance | ($30.0m) | $0 | $0 | — | $0 | $0 | ($65.0m) | $0 | ($7.0m) | |
| Net cash transferred on sale of Houston Franchise | — | — | — | — | — | $0 | $0 | ($73.9m) | $0 | |
| Purchases of premises and equipment and others | ($8.6m) | ($10.0m) | ($14.3m) | ($5.6m) | ($6.6m) | ($10.6m) | ($10.9m) | ($7.4m) | ($7.7m) | |
| Proceeds from sales of premises and equipment | $30.7m | $911k | $5.2m | $13.5m | $44k | $0 | $535k | $205k | $14.1m | |
| Proceeds from sales of repossessed assets and other real estate owned | — | — | — | — | $16k | $6.4m | $2.5m | $0 | $2.7m | |
| Cash paid in business acquisition, net | $0 | $0 | ($14.4m) | $0 | ($1.0m) | $0 | ($2.0m) | $0 | $0 | |
| Proceeds from bank owned life insurance death benefit | — | — | — | — | — | $0 | $0 | $1.2m | $0 | |
| Net increase in demand, savings and money market accounts | ($663.6m) | ($431.0m) | ($308.8m) | $353.3m | $603.0m | $1.0b | $281.8m | $256.9m | $170.7m | |
| Net (decrease) increase in time deposits | $409.2m | $140.7m | $18.8m | ($378.8m) | ($703.7m) | $390.4m | $568.8m | $270.6m | ($238.4m) | |
| Proceeds from advances from the Federal Home Loan Bank | $1.8b | $1.3b | $1.8b | $750.0m | $485.5m | $1.1b | $2.0b | $1.5b | $380.0m | |
| Repayments of advances from the Federal Home Loan Bank | ($1.5b) | ($1.3b) | ($1.7b) | ($935.1m) | ($729.6m) | ($1.0b) | ($2.2b) | ($1.4b) | ($413.4m) | |
| Redemption of senior notes | — | — | — | — | — | — | $0 | $0 | ($60.0m) | |
| Disbursements arising from stock based compensation, net | $0 | $0 | ($1.7m) | ($917k) | ($2.1m) | ($1.1m) | ($523k) | ($1.6m) | ($248k) | |
| Beginning of period | $153.4m | $85.7m | $121.3m | $214.4m | $274.2m | $290.6m | $321.9m | $590.4m | $470.2m | |
| Net cash provided by operating activities | $73.3m | $62.2m | $78.4m | $57.2m | $67.4m | ($49.2m) | $26.7m | $82.2m | $137.0m | |
| Purchases of investment securities | ($362.9m) | ($243.9m) | ($489.1m) | ($409.1m) | ($530.8m) | ($457.4m) | ($349.7m) | ($786.6m) | ($1.2b) | |
| Maturities, sales, calls and paydowns of investment securities | $686.2m | $311.8m | $548.9m | $815.8m | $531.7m | $292.0m | $218.5m | $746.8m | $654.4m | |
| Net cash used in investing activities | $7.6m | $206.5m | $205.8m | $286.3m | $385.3m | ($1.4b) | ($606.6m) | ($576.7m) | ($47.8m) | |
| Net proceeds from issuance of common stock | $0 | $17.9m | $29.2m | $0 | $0 | $0 | $0 | $155.8m | $0 | |
| Repurchase of common stock-Class A | — | — | $0 | $0 | ($36.3m) | ($72.1m) | ($4.9m) | ($7.6m) | ($33.0m) | |
| Dividends paid | — | — | — | $0 | $0 | ($12.2m) | ($12.1m) | ($12.8m) | ($15.1m) | |
| Net cash (used in) provided by financing activities | ($62.4m) | ($336.4m) | ($248.6m) | ($250.5m) | ($392.9m) | $1.5b | $611.2m | $763.0m | ($209.4m) | |
| Net (decrease) increase in cash and cash equivalents and restricted cash | $18.5m | ($67.7m) | $35.6m | $93.1m | $59.8m | $16.4m | $31.3m | $268.5m | ($120.2m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.